Human Apolipoprotein A-II (Apo A2) ELISA Kit

* Cieluch A et al. (2020) Is it time to change the goals of lipid management in type 1 diabetes mellitus? Changes in apolipoprotein levels during the first year of type 1 diabetes mellitus. Prospective InLipoDiab1 study. Arch. Med. Sci. 18:1-8.

• https://www.archivesofmedicalscience.com/Is-it-time-to-change-the-goals-of-lipid-management-in-type-1-diabetes-mellitus-Changes,125529,0,2.html

* Hori M et al. (2014) Association of pancreatic fatty infiltration with pancreatic ductal adenocarcinoma. Clin Transl Gastroenterol. 5(3): e53.

• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972693/pdf/ctg20145a.pdf

* Nichols SKF et al. (2013) Impaired lipid transport in gestational diabetes mellitus. Journal of Diabetes Research & Clinical Metabolism. doi: 10.724/2050-0866-2-22

• http://www.hoajonline.com/journals/pdf/2050-0866-2-22.pdf

* Miyamoto-Sasaki M et al. (2013) Pitavastatin increases HDL particles functionally preserved with cholesterol efflux capacity and antioxidative actions in dyslipidemic patients. J Atheroscler Thromb. 20(9):708-16.

• https://www.jstage.jst.go.jp/article/jat/20/9/20_17210/_pdf

* Hama S (2013) Investigating Changes in the Composition and the Function of High Density Lipoprotein after Roux-n-Y Bariatric Surgery. University of Manchester.

• https://www.research.manchester.ac.uk/portal/files/54550621/FULL_TEXT.PDF

* Flood-Nichols SK et al. (2013) Longitudinal Analysis of Maternal Plasma Apolipoproteins in Pregnancy: A Targeted Proteomics Approach. Molecular & Cellular Proteomics 12.1

• http://www.mcponline.org/content/12/1/55.long

* Felix K et al. (2013) Serum protein signatures differentiating autoimmune pancreatitis versus pancreatic cancer. PLoS One. 8(12):e82755.

• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857261/pdf/pone.0082755.pdf

* Xue A et al. (2010) Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis. Br. J. Cancer 103(3):391-400

• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920018/